Bruce Y. Lee, MD, MBA
Bruce Y. Lee, MD, MBA is currently Associate Professor of International Health and Director of Operations Research at the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health.
Previously, he was an Associate Professor at the University of Pittsburgh, where he founded and directs the Public Health and Infectious Diseases Computational and Operations Research (PHICOR) group that specializes in designing economic, and operational computer models that help decision makers tackle infectious diseases of global importance. He is the Scientific Lead for the HERMES Project and the RHEA Project. His funding has included grants from the Bill and Melinda Gates Foundation, the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), National Science Foundation (NSF), National Library of Medicine (NLM), and the Pennsylvania Department of Health.
His previous positions include serving as Senior Manager at Quintiles Transnational where he led teams that developed economic and operational models for a variety of clients in the pharmaceutical, biotechnology, and medical device industries, working in biotechnology equity research at Montgomery Securities, and co-founding Integrigen, a biotechnology/bioinformatics company.
Dr. Lee has authored over 150 scientific publications (including over 80 first author and over 35 last author) as well as three books: “Principles and Practice of Clinical Trial Medicine”, “What If… ? : Survival Guide for Physician”s, and “Medical Notes : Clinical Medicine Pocket Guide”. He is an Associate Editor for the journal Vaccine and Area Series Editor for the Wiley Series on Modeling and Simulation. He and his work have garnered attention in leading media outlets such as the New York Times, Los Angeles Times, Businessweek, U.S. News and World Report, Nature Medicine, and National Public Radio (NPR). Dr. Lee received his B.A. from Harvard University, M.D. from Harvard Medical School, and M.B.A. from the Stanford Graduate School of Business. He is board-certified in Internal Medicine, having completed his residency training at the University of California, San Diego.
- Page last reviewed:June 1, 2015
- Page last updated:June 1, 2015
- Content source: